Literature DB >> 7983747

Congo red prolongs the incubation period in scrapie-infected hamsters.

L Ingrosso1, A Ladogana, M Pocchiari.   

Abstract

In scrapie-infected cells, Congo red inhibits both the replication of the infectious agent and accumulation of the protease-resistant form of PrP (PrP-res). In this report, we show that Congo red prolongs the incubation periods of hamsters experimentally infected with two different strains of scrapie.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7983747      PMCID： PMC188599          DOI： 10.1128/JVI.69.1.506-508.1995

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  21 in total

1.  Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain.

Authors:  B Chesebro; R Race; K Wehrly; J Nishio; M Bloom; D Lechner; S Bergstrom; K Robbins; L Mayer; J M Keith
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

2.  A cellular gene encodes scrapie PrP 27-30 protein.

Authors:  B Oesch; D Westaway; M Wälchli; M P McKinley; S B Kent; R Aebersold; R A Barry; P Tempst; D B Teplow; L E Hood
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

3.  Congo red inhibition of scrapie agent replication.

Authors:  B Caughey; D Ernst; R E Race
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

4.  The reticuloendothelial system in scrapie pathogenesis.

Authors:  B Ehlers; R Rudolph; H Diringer
Journal:  J Gen Virol       Date:  1984-02       Impact factor: 3.891

Review 5.  Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts).

Authors:  G G Glenner
Journal:  N Engl J Med       Date:  1980-06-12       Impact factor: 91.245

6.  The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection.

Authors:  R H Kimberlin; C A Walker
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

7.  Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and congo red [corrected].

Authors:  B Caughey; K Brown; G J Raymond; G E Katzenstein; W Thresher
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

8.  Heparin-like molecules bind differentially to prion-proteins and change their intracellular metabolic fate.

Authors:  R Gabizon; Z Meiner; M Halimi; S A Ben-Sasson
Journal:  J Cell Physiol       Date:  1993-11       Impact factor: 6.384

9.  Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen.

Authors:  B Ehlers; H Diringer
Journal:  J Gen Virol       Date:  1984-08       Impact factor: 3.891

Review 10.  Prions and related neurological diseases.

Authors:  M Pocchiari
Journal:  Mol Aspects Med       Date:  1994
View more
  35 in total

1.  Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation.

Authors:  K Doh-Ura; T Iwaki; B Caughey
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Mimicking dominant negative inhibition of prion replication through structure-based drug design.

Authors:  V Perrier; A C Wallace; K Kaneko; J Safar; S B Prusiner; F E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  Methods for studying prion protein (PrP) metabolism and the formation of protease-resistant PrP in cell culture and cell-free systems. An update.

Authors:  B Caughey; G J Raymond; S A Priola; D A Kocisko; R E Race; R A Bessen; P T Lansbury; B Chesebro
Journal:  Mol Biotechnol       Date:  1999-11       Impact factor: 2.695

4.  Transmissible spongiform encephalopathies: in-vitro evaluation of the therapeutic potentiality of new molecules.

Authors:  G Carcassola; M L Giannino; F Riva; W Ponti
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

5.  Inhibition of protease-resistant prion protein accumulation in vitro by curcumin.

Authors:  Byron Caughey; Lynne D Raymond; Gregory J Raymond; Laura Maxson; Jay Silveira; Gerald S Baron
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

6.  A porphyrin increases survival time of mice after intracerebral prion infection.

Authors:  David A Kocisko; Winslow S Caughey; Richard E Race; Grant Roper; Byron Caughey; John D Morrey
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

7.  Opposite effects of dextran sulfate 500, the polyene antibiotic MS-8209, and Congo red on accumulation of the protease-resistant isoform of PrP in the spleens of mice inoculated intraperitoneally with the scrapie agent.

Authors:  V Beringue; K T Adjou; F Lamoury; T Maignien; J P Deslys; R Race; D Dormont
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

8.  New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products.

Authors:  David A Kocisko; Gerald S Baron; Richard Rubenstein; Jiancao Chen; Salomon Kuizon; Byron Caughey
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 9.  Hormesis and medicine.

Authors:  Edward J Calabrese
Journal:  Br J Clin Pharmacol       Date:  2008-06-28       Impact factor: 4.335

10.  Tetracyclines affect prion infectivity.

Authors:  Gianluigi Forloni; Selina Iussich; Tazeen Awan; Laura Colombo; Nadia Angeretti; Laura Girola; Ilaria Bertani; Giorgio Poli; Maria Caramelli; Maria Grazia Bruzzone; Laura Farina; Lucia Limido; Giacomina Rossi; Giorgio Giaccone; James W Ironside; Orso Bugiani; Mario Salmona; Fabrizio Tagliavini
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.